Executive Director

Sabine Gaugris

Sabine brings extensive experience in health economics and outcomes research across multiple disease areas within the pharmaceutical industry and consulting. Over the past 20 years, she has led successful HTA submissions in the UK and managed outcomes research studies, including network meta-analyses, survival analyses, and observational studies. She has also developed global value dossiers, covering core health economics components from systematic reviews to economic models.

In her current role, Sabine provides strategic support and project direction, leading a team of approximately 25 people, ensuring high-quality deliverables and an exceptional client experience. Before joining FIECON, she was a Senior HEOR/HTA Manager for Abbvie UK, where she managed national market access for Venclyxto. She has also held managerial positions in HEOR at Janssen UK, Merck & Co. Inc Global, and Merck Sharp & Dohme in France.

Sabine holds an MSc in Health Economics from Paris Dauphine University and an MSc in Cell Biology & Physiology from Paris XI University.

Contact Sabine

Key facts

Leadership in HTA and outcomes research

Led numerous successful HTA submissions and outcomes studies, including survival and quality of life analyses.

Expertise in global value dossiers

Developed health economics components and global value dossiers for pharmaceutical clients.

Strategic project management

Oversees a team ensuring delivery of high-quality deliverables and client satisfaction.

Experience in range of therapy areas:

Haematology, cardiovascular
Respiratory
Osteoporosis, Rheumatology
Ophthalmology, rare diseases

FIECON exceeds my expectations by genuinely trying to achieve the best outcomes for our company. Their flexibility to adapt to unexpected changes and apply technical rigour, while respecting the commercial focus of the company is unparalleled. We see FIECON as part of our extended team.”

Senior Market Access Manager, Mid-sized Pharma

It was brilliantly smart and very well explained. It seems obvious now but that is what genius is, making complex things appear simple.”

Associate Director, Mid-sized Pharma

FIECON are my go to trusted partner. The team deliver high-quality work to timeline, every time. But more than this, FIECON has worked as part of our team, working towards achieving the best possible outcome by providing high level strategic input and challenge during our discussions.”

Market Access Director, Small Biotech

FIECON’s highly skilled expert team helped us to successfully tackle a number of tough pricing and access challenges. Apart from their flawless technical expertise, we have a reliable thought partner to pressure test new ideas and strategies that have a broader relevance than purely health economic aspects.”

Disease Area Director, Big Pharma

The pricing and market access research was a high quality work project, which included detailed information to define the overall and country strategy while the gap analysis was instrumental in the next steps preparation. ”

Executive Director, Biotech

FIECON’s strategic approach to problem solving is a breath of fresh air. We highly value their HTA knowledge and expertise, and they consistently deliver the best solution for us.”

Value Demonstration & Access Lead, Big Pharma

It is a pleasure to work with FIECON. The team are passionate about what they do and it really shows in their high-quality, creative solutions. Working with FIECON gives your projects the highest chance of success.”

Senior Vice President, Small Biotech

FIECON’s team is highly experienced, commercially focused, responsive and flexible. A particular strength I highlight is that FIECON’s team becomes a true partner with all company functions that they interact with. ”

Executive Director, Biotech